CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Restricted Cash and Investments
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Restricted Cash and Investments of $1.43 million as of 2019-09-28, per its 10-Q filed 2019-11-06.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndInvestments · last filed 2019-11-06
- 2019-09-28: Restricted Cash and Investments $1.43M.
- 2019-06-29: Restricted Cash and Investments $1.50M.
- 2019-03-30: Restricted Cash and Investments $1.50M.
- 2018-12-29: Restricted Cash and Investments $1.41M.
| Period end | Restricted Cash and Investments |
|---|---|
| 2019-09-28 | $1.43M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $1.50M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $1.50M 10-Q · filed 2019-05-07 |
| 2018-12-29 | $1.41M 10-Q · filed 2019-11-06 |
| 2018-09-29 | $2.58M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $2.47M 10-Q · filed 2019-07-31 |
| 2018-03-31 | $2.02M 10-Q · filed 2019-05-07 |
| 2017-12-30 | $1.95M 10-Q · filed 2018-11-07 |
| 2017-09-30 | $1.94M 10-Q · filed 2018-11-07 |
| 2017-07-01 | $1.99M 10-Q · filed 2018-08-08 |
| 2017-04-01 | $1.76M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $1.74M 10-Q · filed 2017-11-09 |
| 2016-09-24 | $1.82M 10-Q · filed 2017-11-09 |
| 2016-06-25 | $1.76M 10-Q · filed 2017-08-09 |
| 2016-03-26 | $1.79M 10-Q · filed 2017-05-10 |
| 2015-12-26 | $1.75M 10-K · filed 2017-02-14 |
| 2014-12-27 | $0.00 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |